NCT00334503View on ClinicalTrials.gov

Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Miglitol

Trial Locations (13)

Unknown

Aichi

Chiba

Fukuoka

Gunma

Hokkaido

Ibaraki

Kagoshima

Kanagawa

Kumamoto

Miyazaki

Osaka

Ōita

Saitama

All Listed Sponsors
lead

Sanwa Kagaku Kenkyusho Co., Ltd.

INDUSTRY

NCT00334503 - Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide | Biotech Hunter | Biotech Hunter